Redwood Investment Management »

Halozyme Therapeutics shares owned by Redwood Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Redwood Investment Management from 13F filings

Historical chart of Redwood Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Redwood Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Redwood Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 16k 73.33

More positions owned by Redwood Investment Management

Vanguard S&p 500 Etf S&p 500 Etf Shs (VOO)
Invesco S&P 500 Momentum ETF S&p 500 Momntm (SPMO)
LeaderShares AlphaFactor US Ldrshs Alpfact (LSAF)
Ishares Msci Eafe Etf Msci Eafe Etf (EFA)
Spdr Portfolio S&p 500 Growt Prtflo S&p500 Gw (SPYG)
LeaderShares AlphaFactor Tacti Leadershs Alphaf (LSAT)
Invesco QQQ Trust Series 1 Unit Ser 1 (QQQ)
Schwab International Small Cap Etf Intl Sceqt Etf (SCHC)
Vanguard Ftse All World Ex Us Etf Ftse Smcap Etf (VSS)
LeaderShares Dynamic Yield ETF Leadershares Dy (DYLD)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard FTSE Developed Market Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
State Street SPDR Portfolio Lo Portfolio Ln Tsr (SPTL)

View all positions for Redwood Investment Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics